Windlas Biotech’s Stock Faces Decline, But Shows Potential for Growth in Pharmaceutical Industry
Windlas Biotech, a smallcap pharmaceutical company, experienced a -7.59% decline in its stock price on November 4th, 2024, underperforming the
Read More